期刊
JOURNAL OF CLINICAL MEDICINE
卷 10, 期 22, 页码 -出版社
MDPI
DOI: 10.3390/jcm10225284
关键词
heuristics; bias; artificial intelligence; machine learning; health outcomes; population health; ophthalmology; electronic health record
资金
- Macular Degeneration Foundation, Inc.
- Carl Marshall Reeves & Mildred Almen Reeves Foundation, Inc.
The use of AI and ML in clinical care shows promise in improving patient health outcomes and reducing health disparities, but inherent biases and potential risks of harm need to be addressed. Developing multi-modal workflows to minimize limitations and considering rapidly evolving AI technologies, expanding data sources, and changing regulatory landscapes are crucial in enhancing clinical decision making and reducing health inequity.
The use of artificial intelligence (AI) and machine learning (ML) in clinical care offers great promise to improve patient health outcomes and reduce health inequity across patient populations. However, inherent biases in these applications, and the subsequent potential risk of harm can limit current use. Multi-modal workflows designed to minimize these limitations in the development, implementation, and evaluation of ML systems in real-world settings are needed to improve efficacy while reducing bias and the risk of potential harms. Comprehensive consideration of rapidly evolving AI technologies and the inherent risks of bias, the expanding volume and nature of data sources, and the evolving regulatory landscapes, can contribute meaningfully to the development of AI-enhanced clinical decision making and the reduction in health inequity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据